Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Managing Side Effects on Ocular Surface Caused by Glaucoma Eye Drops

Author(s): Antonio Ferreras, Michele Figus, Paolo Fogagnolo, Michele Iester and Paolo Frezzotti

Volume 26, Issue 22, 2019

Page: [4223 - 4224] Pages: 2

DOI: 10.2174/092986732622190920092210

« Previous Next »
[1]
Quigley, H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res., 1999, 18, 39-57.
[2]
World Health Organization. Blindness and vision impairment prevention: Priority eyes diseases: Glaucoma: Available at. https://www.who.int/blindness/causes/priority/en/index6.html (Accessed July 21, 2019).
[3]
Quigley, H.A.; Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol., 2006, 90, 262-267.
[4]
Mastropasqua, R.; Agnifili, L.; Mastropasqua, L. Structural and molecular tear film changes in glaucoma. Curr. Med. Chem., 2019, 26(22), 4225-4240.
[5]
Fogagnolo, P.; Torregrossa, G.; Tranchina, L.; Ferreras, A.; De Cillà, S.; Labbé, A.; Figus, M.; Ottobelli, L.; Rossetti, L. Tear film osmolarity, ocular surface disease and glaucoma: A review. Curr. Med. Chem., 2019, 26(22), 4241-4252.
[6]
Roberti, G.; Tanga, L.; Manni, G.; Riva, I.; Verticchio, A.C.; Berardo, F.; Carnevale, C.; Oddone, F. Tear film, conjunctival and corneal modifications induced by glaucoma treatment. Curr. Med. Chem., 2019, 26(22), 4253-4261.

Rights & Permissions Print Cite
Article Metrics
43
7
© 2024 Bentham Science Publishers | Privacy Policy